Effects of IL1B single nucleotide polymorphisms on depressive and anxiety symptoms are determined by severity and type of life stress

Brain, Behavior, and Immunity

Volumn 56, Issue , 2016, Pages 96-104

  Kovacs, David ^a,b   Eszlari, Nora ^a,b   Petschner, Peter ^a,b   Pap, Dorottya ^a   Vas, Szilvia ^a,b   Kovacs, Peter ^a,c   Gonda, Xenia ^a,b   Juhasz, Gabriella ^a,b,d   Bagdy, Gyorgy ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Anxiety; Cytokines; Depression; Interleukin 1 ; Stress

Indexed keywords

INTERLEUKIN 1BETA; IL1B PROTEIN, HUMAN;

ADULT; ALLELE; ANXIETY DISORDER; ARTICLE; BRIEF SYMPTOM INVENTORY; CHILDHOOD; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; ENVIRONMENTAL STRESS; ETHNIC GROUP; FEMALE; GENETIC RISK; HEREDITY; HUMAN; HUNGARIAN; HUNGARY; IL1B GENE; LIFE EVENT; LIFE STRESS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOM; ADOLESCENT; CHILDHOOD TRAUMA SURVIVOR; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; MENTAL STRESS; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; ADULT SURVIVORS OF CHILD ADVERSE EVENTS; ANXIETY DISORDERS; DEPRESSIVE DISORDER; FEMALE; GENE-ENVIRONMENT INTERACTION; HUMANS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84958568010     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2016.02.012     Document Type: Article

References (58)

1. Alheim K., Bartfai T. The interleukin-1 system: receptors, ligands, and ICE in the brain and their involvement in the fever response. Ann. N. Y. Acad. Sci. 1998, 840:51-58.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2013, fifth ed.
3. Anisman H., Hayley S. Inflammatory factors contribute to depression and its comorbid conditions. Sci. Signal. 2012, 5:pe45.
4. Antal P., Millinghoffer A., Hullám G., Szalai C., Falus A. A bayesian view of challenges in feature selection: feature aggregation, multiple targets, redundancy and interaction. JMLR Workshop and Conference Proceedings 2008, 74-89. Antwerpen, Belgium. Y. Saeys, H. Liu, Iñ. Inza, L. Wehenkel, Y. Van de Peer (Eds.).
5. Antal P., Millinghoffer A., Hullam G., Hajos G., Sarkozy P., Szalai C.A.F. Bayesian, Systems-based, Multilevel Analysis of Biomarkers of Complex Phenotypes: From Interpretation to Decisions 2014, 318-360. Oxford University Press.
6. Baganz N.L., Blakely R.D. A dialogue between the immune system and brain, spoken in the language of serotonin. ACS Chem. Neurosci. 2013, 4:48-63.
7. Baune B.T., Dannlowski U., Domschke K., Janssen D.G., Jordan M.A., Ohrmann P., Bauer J., Biros E., Arolt V., Kugel H., Baxter A.G., Suslow T. The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression. Biol. Psychiatry 2010, 67:543-549.
8. Bernstein D.P., Fink L., Handelsman L., Foote J., Lovejoy M., Wenzel K., Sapareto E., Ruggiero J. Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am. J. Psychiatry 1994, 151:1132-1136.
9. Borkowska P., Kucia K., Rzezniczek S., Paul-Samojedny M., Kowalczyk M., Owczarek A., Suchanek R., Medrala T., Kowalski J. Interleukin-1beta promoter (-31T/C and -511C/T) polymorphisms in major recurrent depression. J. Mol. Neurosci. 2011, 44:12-16.
10. Borsini A., Zunszain P.A., Thuret S., Pariante C.M. The role of inflammatory cytokines as key modulators of neurogenesis. Trends Neurosci. 2015, 38:145-157.
11. Brugha T., Bebbington P., Tennant C., Hurry J. The list of threatening experiences: a subset of 12 life event categories with considerable long-term contextual threat. Psychol. Med. 1985, 15:189-194.
12. Capuron L., Miller A.H. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol. Ther. 2011, 130:226-238.
13. Cohen-Woods S., Craig I.W., McGuffin P. The current state of play on the molecular genetics of depression. Psychol. Med. 2013, 43:673-687.
14. Converge-consortium Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature 2015, 523:588-591.
15. Dantzer R., O'Connor J.C., Lawson M.A., Kelley K.W. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 2011, 36:426-436.
16. del Rey A., Apkarian A.V., Martina M., Besedovsky H.O. Chronic neuropathic pain-like behavior and brain-borne IL-1beta. Ann. N. Y. Acad. Sci. 2012, 1262:101-107.
17. Derogatis L.R., Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol. Med. 1983, 13:595-605.
18. Dhabhar F.S. Effects of stress on immune function: the good, the bad, and the beautiful. Immunol. Res. 2014, 58:193-210.
19. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctôt K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
20. Freeman B., Smith N., Curtis C., Huckett L., Mill J., Craig I.W. DNA from buccal swabs recruited by mail: evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behav. Genet. 2003, 33:67-72.
21. Giles J.A., Greenhalgh A.D., Davies C.L., Denes A., Shaw T., Coutts G., Rothwell N.J., McColl B.W., Allan S.M. Requirement for interleukin-1 to drive brain inflammation reveals tissue-specific mechanisms of innate immunity. Eur. J. Immunol. 2014.
22. Girotti M., Donegan J.J., Morilak D.A. Chronic intermittent cold stress sensitizes neuro-immune reactivity in the rat brain. Psychoneuroendocrinology 2011, 36:1164-1174.
23. Guhaniyogi J., Brewer G. Regulation of mRNA stability in mammalian cells. Gene 2001, 265:11-23.
24. Hall S.K., Perregaux D.G., Gabel C.A., Woodworth T., Durham L.K., Huizinga T.W., Breedveld F.C., Seymour A.B. Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum. 2004, 50:1976-1983.
25. Hartwell K.J., Moran-Santa Maria M.M., Twal W.O., Shaftman S., DeSantis S.M., McRae-Clark A.L., Brady K.T. Association of elevated cytokines with childhood adversity in a sample of healthy adults. J. Psychiatr. Res. 2013, 47:604-610.
26. Hoeting J.D., Raftery A.E., Volinsky C.T. Bayesian model averaging: a tutorial. Stat. Sci. 1999, 14:382-417.
27. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 2009, 71:171-186.
28. Hullam G., Antal P. The effect of parameter priors on Bayesian relevance and effect size measures. Period. Polytech. Electr. Eng. Comput. Sci. 2013, 2:35-48.
29. Hullam G., Juhasz G., Bagdy G., Antal P. Beyond structural equation modeling: model properties and effect size from a Bayesian viewpoint. An example of complex phenotype-genotype associations in depression. Neuropsychopharmacol. Hung. 2012, 14:273-284.
30. Juhasz G., Chase D., Pegg E., Downey D., Toth Z.G., Stones K., Platt H., Mekli K., Payton A., Elliott R., Anderson I.M., Deakin J.F. CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms. Neuropsychopharmacology 2009, 34:2019-2027.
31. Juhasz G., Dunham J.S., McKie S., Thomas E., Downey D., Chase D., Lloyd-Williams K., Toth Z.G., Platt H., Mekli K., Payton A., Elliott R., Williams S.R., Anderson I.M., Deakin J.F. The CREB1-BDNF-NTRK2 pathway in depression: multiple gene-cognition-environment interactions. Biol. Psychiatry 2011, 69:762-771.
32. Juhasz G., Hullam G., Eszlari N., Gonda X., Antal P., Anderson I.M., Hokfelt T.G., Deakin J.F., Bagdy G. Brain galanin system genes interact with life stresses in depression-related phenotypes. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:E1666-E1673.
33. Juhasz G., Gonda X., Hullam G., Eszlari N., Kovacs D., Lazary J., Pap D., Petschner P., Elliott R., Deakin J.F., Anderson I.M., Antal P., Lesch K.P., Bagdy G. Variability in the effect of 5-HTTLPR on depression in a large European population: the role of age, symptom profile, type and intensity of life stressors. PLoS ONE 2015, 10.
34. Kendler K.S., Prescott C.A. A population-based twin study of lifetime major depression in men and women. Arch. Gen. Psychiatry 1999, 56:39-44.
35. Kim J.M., Stewart R., Kim S.Y., Kang H.J., Jang J.E., Kim S.W., Shin I.S., Park M.H., Yoon J.H., Park S.W., Kim Y.H., Yoon J.S. A one year longitudinal study of cytokine genes and depression in breast cancer. J. Affect. Disord. 2013, 148:57-65.
36. Lawson M.A., McCusker R.H., Kelley K.W. Interleukin-1 beta converting enzyme is necessary for development of depression-like behavior following intracerebroventricular administration of lipopolysaccharide to mice. J. Neuroinflammation 2013, 10:54.
37. Laye S., Liege S., Li K.S., Moze E., Neveu P.J. Physiological significance of the interleukin 1 receptor accessory protein. NeuroImmunoModulation 2001, 9:225-230.
38. Lazary J., Lazary A., Gonda X., Benko A., Molnar E., Juhasz G., Bagdy G. New evidence for the association of the serotonin transporter gene (SLC6A4) haplotypes, threatening life events, and depressive phenotype. Biol. Psychiatry 2008, 64:498-504.
39. Ma X., Wang R., Zhao X., Zhang C., Sun J., Li J., Zhang L., Shao T., Ruan L., Chen L., Xu Y., Pan J. Antidepressant-like effect of flaxseed secoisolariciresinol diglycoside in ovariectomized mice subjected to unpredictable chronic stress. Metab. Brain Dis. 2013, 28:77-84.
40. Madigan D., Andersson S., Perlman M., Volinsky C.T. Bayesian model averaging and model selection for Markov equivalence classes of acyclic digraphs. Commun. Stat. Theory Methods 1996, 25:2493-2519.
41. Maes M., Bosmans E., Meltzer H.Y., Scharpe S., Suy E. Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?. Am. J. Psychiatry 1993, 150:1189-1193.
42. McCulley M.C., Day I.N., Holmes C. Association between interleukin 1-beta promoter (-511) polymorphism and depressive symptoms in Alzheimer's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004, 124B:50-53.
43. Michel M., Schmidt M.J., Mirnics K. Immune system gene dysregulation in autism and schizophrenia. Dev. Neurobiol. 2012, 72:1277-1287.
44. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741.
45. Pascoe M.C., Crewther S.G., Carey L.M., Crewther D.P. Inflammation and depression: why poststroke depression may be the norm and not the exception. Int. J. Stroke 2011, 6:128-135.
46. Plomin R., Haworth C.M., Davis O.S. Common disorders are quantitative traits. Nat. Rev. Genet. 2009, 10:872-878.
47. Pollack M.H. Comorbid anxiety and depression. J. Clin. Psychiatry 2005, 66(Suppl. 8):22-29.
48. Raison C.L., Miller A.H. The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Mol. Psychiatry 2013, 18:15-37.
49. Rosa A., Peralta V., Papiol S., Cuesta M.J., Serrano F., Martinez-Larrea A., Fananas L. Interleukin-1beta (IL-1beta) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004, 124B:10-14.
50. Rothwell N.J., Luheshi G.N. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 2000, 23:618-625.
51. Roy-Byrne P.P., Davidson K.W., Kessler R.C., Asmundson G.J., Goodwin R.D., Kubzansky L., Lydiard R.B., Massie M.J., Katon W., Laden S.K., Stein M.B. Anxiety disorders and comorbid medical illness. Gen. Hosp. Psychiatry 2008, 30:208-225.
52. Scott K.M., Bruffaerts R., Tsang A., Ormel J., Alonso J., Angermeyer M.C., Benjet C., Bromet E., de Girolamo G., de Graaf R., Gasquet I., Gureje O., Haro J.M., He Y., Kessler R.C., Levinson D., Mneimneh Z.N., Oakley Browne M.A., Posada-Villa J., Stein D.J., Takeshima T., Von Korff M. Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health Surveys. J. Affect. Disord. 2007, 103:113-120.
53. Semple B.D., Blomgren K., Gimlin K., Ferriero D.M., Noble-Haeusslein L.J. Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species. Prog. Neurobiol. 2013, 106-107:1-16.
54. Serre D., Gurd S., Ge B., Sladek R., Sinnett D., Harmsen E., Bibikova M., Chudin E., Barker D.L., Dickinson T., Fan J.B., Hudson T.J. Differential allelic expression in the human genome: a robust approach to identify genetic and epigenetic cis-acting mechanisms regulating gene expression. PLoS Genet. 2008, 4.
55. Slavich G.M., Irwin M.R. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol. Bull. 2014, 140:774-815.
56. Stephens M., Balding D.J. Bayesian statistical methods for genetic association studies. Nat. Rev. Genet. 2009, 10:681-690.
57. Wohleb E.S., Patterson J.M., Sharma V., Quan N., Godbout J.P., Sheridan J.F. Knockdown of interleukin-1 receptor type-1 on endothelial cells attenuated stress-induced neuroinflammation and prevented anxiety-like behavior. J. Neurosci. 2014, 34:2583-2591.
58. Yu Y.W., Chen T.J., Hong C.J., Chen H.M., Tsai S.J. Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response. Neuropsychopharmacology 2003, 28:1182-1185.